Westminster Pharmaceuticals LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 14, 2024
  • 5 Class I recalls
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 10 5 Class I (50%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Westminster Pharmaceuticals LLC has 10 FDA recalls (5 Class I), 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Westminster Pharmaceuticals LLC" is on file.

What these totals cover: FDA records filed under the name "Westminster Pharmaceuticals LLC" and its spelling variant "Westminster Pharmaceuticals".

Latest recall
D-0581-2025 · Class II · Aug 6, 2025
Latest inspection
Feb 14, 2024 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls10 (5 Class I)Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Westminster Pharmaceuticals LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Westminster Pharmaceuticals LLC: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 8 recall records (5 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500020
202410000
202300000
202200000
202100000
202000000
201900000
201800085
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Westminster Pharmaceuticals LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Westminster Pharmaceuticals LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

10 recall records from Aug 3, 2018 to Aug 6, 2025.

NumberClassProductDate
D-0581-2025Class IIMetoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General…Aug 6, 2025
D-0582-2025Class IIMetoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC…Aug 6, 2025
D-0302-2019Class IIWestminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc…Oct 29, 2018
D-0300-2019Class IIWestminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc…Oct 29, 2018
D-0301-2019Class IIWestminster Irbesartan Tablets, USP 150 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc…Oct 29, 2018
D-1181-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx…Aug 3, 2018
D-1179-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx…Aug 3, 2018
D-1180-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx…Aug 3, 2018
D-1182-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only…Aug 3, 2018
D-1178-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only…Aug 3, 2018

Recent FDA inspections

1 inspection on Feb 14, 2024.

DateSiteProductClassificationFEI
Feb 14, 2024Tampa, FLDrugsNo Action Indicated (NAI)3016796694
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3016796694Tampa, FL1Feb 14, 2024

Westminster Pharmaceuticals LLC and the FDA: common questions

Has Westminster Pharmaceuticals LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Westminster Pharmaceuticals LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Westminster Pharmaceuticals LLC received an FDA Form 483?

FDA has not published a Form 483 for "Westminster Pharmaceuticals LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Westminster Pharmaceuticals LLC?

The most recent FDA inspection on file ended Feb 14, 2024 at Tampa, FL and was classified NAI. FDA has 1 inspection of Westminster Pharmaceuticals LLC on file.

Has Westminster Pharmaceuticals LLC had an FDA recall?

Yes. Westminster Pharmaceuticals LLC has 10 FDA recalls on record, 5 of them Class I, the most serious class. The most recent started Aug 6, 2025.

Need more than this page shows? Ask about Westminster Pharmaceuticals LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.